Health Catalyst (HCAT) Cash & Current Investments (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Cash & Current Investments data on file, last reported at $108.8 million in Q1 2026.

• Quarterly Cash & Current Investments fell 68.18% year-over-year to $108.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108.8 million (down 68.18% YoY) and the FY2025 annual result came in at $95.7 million, down 75.58% from the prior year.
• Cash & Current Investments advanced to $108.8 million in Q1 2026, from $95.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $425.4 million in Q1 2022 to a low of $91.5 million in Q3 2025.
• A 5-year average of $299.4 million and a median of $343.8 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 59.67% — and 2025, when it sank 76.36%.
• Tracing HCAT's Cash & Current Investments over 5 years: stood at $363.5 million in 2022, then fell by 12.59% to $317.7 million in 2023, then advanced by 23.38% to $392.0 million in 2024, then tumbled by 75.58% to $95.7 million in 2025, then advanced by 13.67% to $108.8 million in 2026.
• The last three Cash & Current Investments figures came in at $108.8 million (Q1 2026), $95.7 million (Q4 2025), and $91.5 million (Q3 2025), per Business Quant data.